Preview Mode Links will not work in preview mode

Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #1: Optimal Application of Immune Checkpoint Inhibitors in Advanced Urothelial Cancer — Dr Balar
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #2: Immune Checkpoint Inhibitors as Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer — Dr Daneshmand
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #3: Integrating Immune Checkpoint Inhibitors into the Current Treatment Paradigm for Non-Muscle-Invasive Bladder Cancer — Dr Kamat
CME information and select...


Aug 13, 2020

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #4: Current and Future Role of Recently Approved Novel Therapies in the Management of Urothelial Bladder Carcinoma — Dr Rosenberg
CME information and select...


Aug 13, 2020

Featuring perspectives from Drs Arjun Balar, Siamak Daneshmand, Ashish M Kamat and Jonathan E Rosenberg on the following topics:

  • Introduction (00:00)
  • Immune checkpoint inhibitors for non-muscle-invasive urothelial bladder cancer (UBC) (4:17)
  • Immune checkpoint inhibitors as neoadjuvant/adjuvant therapy for...